Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.
about
Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@en
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@nl
type
label
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@en
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@nl
prefLabel
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@en
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@nl
P2093
P2860
P356
P1476
Infliximab relieves blood reti ...... thway in a diabetic rat model.
@en
P2093
Guo-Xing Xu
Li-Bin Huang
Mao-Song Xie
Yong-Zheng Zheng
P2860
P304
P356
10.18240/IJO.2017.12.06
P577
2017-12-18T00:00:00Z